Guangdong Zhongsheng Pharmaceutical Co Ltd Strategic Asset Allocation Index

Latest as of September 2023: 15.1%

Guangdong Zhongsheng Pharmaceutical Co Ltd strategic asset allocation index. Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has a Strategic Asset Allocation Index of 15.1% as of September 2023. Strategic assets (PP&E of CN¥688.38 Million plus long-term investments of CN¥-) total CN¥688.38 Million, measured against net assets of CN¥4.56 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of Guangdong Zhongsheng Pharmaceutical Co L to measure how much of total assets are equity-financed.

SAAI

15.1%
Strategic Assets / Net Assets

Strategic Assets

CN¥688.38 Million
PP&E + LT Investments

PP&E

CN¥688.38 Million
CNY

Net Assets

CN¥4.56 Billion
CNY

Strategic Asset Allocation Index of Guangdong Zhongsheng Pharmaceutical Co Ltd (2009–2021)

Strategic asset allocation index of Guangdong Zhongsheng Pharmaceutical Co Ltd from 2009 to 2021. This chart shows how Guangdong Zhongsheng Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 13 annual periods from 2009 to 2021. As of September 2023, the index stands at 15.1%, representing strategic assets of CN¥688.38 Million against net assets of CN¥4.56 Billion CNY. Check Guangdong Zhongsheng Pharmaceutical Co L tangible book value ratio to evaluate the tangible quality of the company's equity base.

Guangdong Zhongsheng Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2009–2021)

Guangdong Zhongsheng Pharmaceutical Co Ltd strategic asset allocation index by year from 2009 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Guangdong Zhongsheng Pharmaceutical Co Ltd from 2009 to 2021, covering 13 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Guangdong Zhongsheng Pharmaceutical Co L market cap and net worth.

Year SAAI Strategic Assets (CNY) PP&E LT Investments Net Assets Change (pp)
2021 17.0% CN¥601.24 Million CN¥601.24 Million CN¥- CN¥3.54 Billion ▲ +1.6 pp
2020 15.4% CN¥557.97 Million CN¥557.97 Million CN¥- CN¥3.63 Billion ▲ +0.3 pp
2019 15.1% CN¥623.55 Million CN¥623.55 Million CN¥- CN¥4.13 Billion ▼ -4.9 pp
2018 20.0% CN¥789.01 Million CN¥657.69 Million CN¥131.33 Million CN¥3.95 Billion ▲ +5.5 pp
2017 14.4% CN¥538.05 Million CN¥490.03 Million CN¥48.03 Million CN¥3.73 Billion ▼ -1.1 pp
2016 15.5% CN¥531.07 Million CN¥506.34 Million CN¥24.74 Million CN¥3.42 Billion ▼ -12.4 pp
2015 27.9% CN¥589.07 Million CN¥579.07 Million CN¥10.00 Million CN¥2.11 Billion ▲ +2.1 pp
2014 25.9% CN¥491.20 Million CN¥491.20 Million CN¥- CN¥1.90 Billion ▼ -4.5 pp
2013 30.3% CN¥528.81 Million CN¥528.81 Million CN¥- CN¥1.74 Billion ▲ +5.7 pp
2012 24.7% CN¥391.21 Million CN¥391.21 Million CN¥- CN¥1.59 Billion ▲ +0.2 pp
2011 24.4% CN¥361.06 Million CN¥361.06 Million CN¥- CN¥1.48 Billion ▲ +10.2 pp
2010 14.3% CN¥198.07 Million CN¥198.07 Million CN¥- CN¥1.39 Billion ▲ +2.9 pp
2009 11.3% CN¥146.96 Million CN¥146.96 Million CN¥- CN¥1.30 Billion —
pp = percentage points